moxifloxacin has been researched along with Hepatic Insufficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barth, J; Burkhardt, O; Drewelow, B; Jäger, D; Mundkowski, R; Welte, T | 1 |
| Chen, YC; Ho, CC; Hu, FC; Luh, KT; Yang, PC; Yu, CJ | 1 |
2 other study(ies) available for moxifloxacin and Hepatic Insufficiency
| Article | Year |
|---|---|
Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment.
Topics: Adult; Aged; Area Under Curve; Ascitic Fluid; Aza Compounds; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Half-Life; Hepatic Insufficiency; Humans; Infusions, Intravenous; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Serum; Time Factors | 2008 |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Antitubercular Agents; Aspartate Aminotransferases; Aza Compounds; Ethambutol; Female; Fluoroquinolones; Hepatic Insufficiency; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Streptomycin; Treatment Outcome; Tuberculosis; Young Adult | 2009 |